img

Global Central Nervous System (CNS) Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Central Nervous System (CNS) Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson’s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer’s) or voluntary motion (in movement disorders).
Central Nervous System (CNS) Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Central Nervous System (CNS) Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from MS Therapeutics and Antipsychotic Drugs are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Central Nervous System (CNS) Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Central Nervous System (CNS) Drug key companies include Johnson & Johnson, Pfizer Inc, Novartis AG, GSK, Eli Lilly, Teva, Otsuka Pharmaceutical Co., Ltd, Biogen Inc and Boehringer Ingelheim, etc. Johnson & Johnson, Pfizer Inc, Novartis AG are top 3 players and held % share in total in 2022.
Central Nervous System (CNS) Drug can be divided into Prescription Drugs and OTC, etc. Prescription Drugs is the mainstream product in the market, accounting for % share globally in 2022.
Central Nervous System (CNS) Drug is widely used in various fields, such as MS Therapeutics, Antipsychotic Drugs, Depression Drugs and Epilepsy Drugs, etc. MS Therapeutics provides greatest supports to the Central Nervous System (CNS) Drug industry development. In 2022, global % share of Central Nervous System (CNS) Drug went into MS Therapeutics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Central Nervous System (CNS) Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Pfizer Inc
Novartis AG
GSK
Eli Lilly
Teva
Otsuka Pharmaceutical Co., Ltd
Biogen Inc
Boehringer Ingelheim
Roche
UCB
Tekeda
Shanghai Fosun
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Segment by Type
Prescription Drugs
OTC

Segment by Application


MS Therapeutics
Antipsychotic Drugs
Depression Drugs
Epilepsy Drugs
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Central Nervous System (CNS) Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Central Nervous System (CNS) Drug introduction, etc. Central Nervous System (CNS) Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Central Nervous System (CNS) Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Central Nervous System (CNS) Drug
1.1 Central Nervous System (CNS) Drug Market Overview
1.1.1 Central Nervous System (CNS) Drug Product Scope
1.1.2 Central Nervous System (CNS) Drug Market Status and Outlook
1.2 Global Central Nervous System (CNS) Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Central Nervous System (CNS) Drug Market Size by Region (2024-2034)
1.4 Global Central Nervous System (CNS) Drug Historic Market Size by Region (2024-2024)
1.5 Global Central Nervous System (CNS) Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Central Nervous System (CNS) Drug Market Size (2024-2034)
1.6.1 North America Central Nervous System (CNS) Drug Market Size (2024-2034)
1.6.2 Europe Central Nervous System (CNS) Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size (2024-2034)
1.6.4 Latin America Central Nervous System (CNS) Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Central Nervous System (CNS) Drug Market Size (2024-2034)
2 Central Nervous System (CNS) Drug Market by Type
2.1 Introduction
2.1.1 Prescription Drugs
2.1.2 OTC
2.2 Global Central Nervous System (CNS) Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Central Nervous System (CNS) Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Central Nervous System (CNS) Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Central Nervous System (CNS) Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Central Nervous System (CNS) Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Central Nervous System (CNS) Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Central Nervous System (CNS) Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Central Nervous System (CNS) Drug Revenue Breakdown by Type (2024-2034)
3 Central Nervous System (CNS) Drug Market Overview by Application
3.1 Introduction
3.1.1 MS Therapeutics
3.1.2 Antipsychotic Drugs
3.1.3 Depression Drugs
3.1.4 Epilepsy Drugs
3.1.5 Others
3.2 Global Central Nervous System (CNS) Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Central Nervous System (CNS) Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Central Nervous System (CNS) Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Central Nervous System (CNS) Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Central Nervous System (CNS) Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Central Nervous System (CNS) Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Central Nervous System (CNS) Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Central Nervous System (CNS) Drug Revenue Breakdown by Application (2024-2034)
4 Central Nervous System (CNS) Drug Competition Analysis by Players
4.1 Global Central Nervous System (CNS) Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Drug as of 2022)
4.3 Date of Key Players Enter into Central Nervous System (CNS) Drug Market
4.4 Global Top Players Central Nervous System (CNS) Drug Headquarters and Area Served
4.5 Key Players Central Nervous System (CNS) Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Central Nervous System (CNS) Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Products, Services and Solutions
5.1.4 Johnson & Johnson Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.1.5 Johnson & Johnson Recent Developments
5.2 Pfizer Inc
5.2.1 Pfizer Inc Profile
5.2.2 Pfizer Inc Main Business
5.2.3 Pfizer Inc Central Nervous System (CNS) Drug Products, Services and Solutions
5.2.4 Pfizer Inc Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.2.5 Pfizer Inc Recent Developments
5.3 Novartis AG
5.3.1 Novartis AG Profile
5.3.2 Novartis AG Main Business
5.3.3 Novartis AG Central Nervous System (CNS) Drug Products, Services and Solutions
5.3.4 Novartis AG Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.3.5 GSK Recent Developments
5.4 GSK
5.4.1 GSK Profile
5.4.2 GSK Main Business
5.4.3 GSK Central Nervous System (CNS) Drug Products, Services and Solutions
5.4.4 GSK Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.4.5 GSK Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Central Nervous System (CNS) Drug Products, Services and Solutions
5.5.4 Eli Lilly Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.5.5 Eli Lilly Recent Developments
5.6 Teva
5.6.1 Teva Profile
5.6.2 Teva Main Business
5.6.3 Teva Central Nervous System (CNS) Drug Products, Services and Solutions
5.6.4 Teva Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.6.5 Teva Recent Developments
5.7 Otsuka Pharmaceutical Co., Ltd
5.7.1 Otsuka Pharmaceutical Co., Ltd Profile
5.7.2 Otsuka Pharmaceutical Co., Ltd Main Business
5.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Products, Services and Solutions
5.7.4 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.7.5 Otsuka Pharmaceutical Co., Ltd Recent Developments
5.8 Biogen Inc
5.8.1 Biogen Inc Profile
5.8.2 Biogen Inc Main Business
5.8.3 Biogen Inc Central Nervous System (CNS) Drug Products, Services and Solutions
5.8.4 Biogen Inc Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.8.5 Biogen Inc Recent Developments
5.9 Boehringer Ingelheim
5.9.1 Boehringer Ingelheim Profile
5.9.2 Boehringer Ingelheim Main Business
5.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Products, Services and Solutions
5.9.4 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.9.5 Boehringer Ingelheim Recent Developments
5.10 Roche
5.10.1 Roche Profile
5.10.2 Roche Main Business
5.10.3 Roche Central Nervous System (CNS) Drug Products, Services and Solutions
5.10.4 Roche Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.10.5 Roche Recent Developments
5.11 UCB
5.11.1 UCB Profile
5.11.2 UCB Main Business
5.11.3 UCB Central Nervous System (CNS) Drug Products, Services and Solutions
5.11.4 UCB Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.11.5 UCB Recent Developments
5.12 Tekeda
5.12.1 Tekeda Profile
5.12.2 Tekeda Main Business
5.12.3 Tekeda Central Nervous System (CNS) Drug Products, Services and Solutions
5.12.4 Tekeda Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.12.5 Tekeda Recent Developments
5.13 Shanghai Fosun
5.13.1 Shanghai Fosun Profile
5.13.2 Shanghai Fosun Main Business
5.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Products, Services and Solutions
5.13.4 Shanghai Fosun Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.13.5 Shanghai Fosun Recent Developments
5.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
5.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Profile
5.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Main Business
5.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Products, Services and Solutions
5.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue (US$ Million) & (2024-2024)
5.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments
6 North America
6.1 North America Central Nervous System (CNS) Drug Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Central Nervous System (CNS) Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Central Nervous System (CNS) Drug Market Dynamics
11.1 Central Nervous System (CNS) Drug Industry Trends
11.2 Central Nervous System (CNS) Drug Market Drivers
11.3 Central Nervous System (CNS) Drug Market Challenges
11.4 Central Nervous System (CNS) Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Central Nervous System (CNS) Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Central Nervous System (CNS) Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Central Nervous System (CNS) Drug Market Size Share by Region (2024-2024)
Table 4. Global Central Nervous System (CNS) Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Central Nervous System (CNS) Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Central Nervous System (CNS) Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Central Nervous System (CNS) Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Central Nervous System (CNS) Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Central Nervous System (CNS) Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Central Nervous System (CNS) Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Central Nervous System (CNS) Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Central Nervous System (CNS) Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Central Nervous System (CNS) Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Central Nervous System (CNS) Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Central Nervous System (CNS) Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Central Nervous System (CNS) Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Central Nervous System (CNS) Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Central Nervous System (CNS) Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Central Nervous System (CNS) Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Central Nervous System (CNS) Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Central Nervous System (CNS) Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Central Nervous System (CNS) Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Central Nervous System (CNS) Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Central Nervous System (CNS) Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Central Nervous System (CNS) Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Central Nervous System (CNS) Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Central Nervous System (CNS) Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Central Nervous System (CNS) Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Central Nervous System (CNS) Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Drug as of 2022)
Table 39. Date of Key Players Enter into Central Nervous System (CNS) Drug Market
Table 40. Global Central Nervous System (CNS) Drug Key Players Headquarters and Area Served
Table 41. Central Nervous System (CNS) Drug Product Solution and Service
Table 42. Global Central Nervous System (CNS) Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Johnson & Johnson Basic Information List
Table 45. Johnson & Johnson Description and Business Overview
Table 46. Johnson & Johnson Central Nervous System (CNS) Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Johnson & Johnson (2024-2024)
Table 48. Johnson & Johnson Recent Developments
Table 49. Pfizer Inc Basic Information List
Table 50. Pfizer Inc Description and Business Overview
Table 51. Pfizer Inc Central Nervous System (CNS) Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Pfizer Inc (2024-2024)
Table 53. Pfizer Inc Recent Developments
Table 54. Novartis AG Basic Information List
Table 55. Novartis AG Description and Business Overview
Table 56. Novartis AG Central Nervous System (CNS) Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Novartis AG (2024-2024)
Table 58. Novartis AG Recent Developments
Table 59. GSK Basic Information List
Table 60. GSK Description and Business Overview
Table 61. GSK Central Nervous System (CNS) Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of GSK (2024-2024)
Table 63. GSK Recent Developments
Table 64. Eli Lilly Basic Information List
Table 65. Eli Lilly Description and Business Overview
Table 66. Eli Lilly Central Nervous System (CNS) Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Eli Lilly (2024-2024)
Table 68. Eli Lilly Recent Developments
Table 69. Teva Basic Information List
Table 70. Teva Description and Business Overview
Table 71. Teva Central Nervous System (CNS) Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Teva (2024-2024)
Table 73. Teva Recent Developments
Table 74. Otsuka Pharmaceutical Co., Ltd Basic Information List
Table 75. Otsuka Pharmaceutical Co., Ltd Description and Business Overview
Table 76. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Otsuka Pharmaceutical Co., Ltd (2024-2024)
Table 78. Otsuka Pharmaceutical Co., Ltd Recent Developments
Table 79. Biogen Inc Basic Information List
Table 80. Biogen Inc Description and Business Overview
Table 81. Biogen Inc Central Nervous System (CNS) Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Biogen Inc (2024-2024)
Table 83. Biogen Inc Recent Developments
Table 84. Boehringer Ingelheim Basic Information List
Table 85. Boehringer Ingelheim Description and Business Overview
Table 86. Boehringer Ingelheim Central Nervous System (CNS) Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Boehringer Ingelheim (2024-2024)
Table 88. Boehringer Ingelheim Recent Developments
Table 89. Roche Basic Information List
Table 90. Roche Description and Business Overview
Table 91. Roche Central Nervous System (CNS) Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Roche (2024-2024)
Table 93. Roche Recent Developments
Table 94. UCB Basic Information List
Table 95. UCB Description and Business Overview
Table 96. UCB Central Nervous System (CNS) Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of UCB (2024-2024)
Table 98. UCB Recent Developments
Table 99. Tekeda Basic Information List
Table 100. Tekeda Description and Business Overview
Table 101. Tekeda Central Nervous System (CNS) Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Tekeda (2024-2024)
Table 103. Tekeda Recent Developments
Table 104. Shanghai Fosun Basic Information List
Table 105. Shanghai Fosun Description and Business Overview
Table 106. Shanghai Fosun Central Nervous System (CNS) Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Shanghai Fosun (2024-2024)
Table 108. Shanghai Fosun Recent Developments
Table 109. Jiangsu Nhwa Pharmaceutical Co., Ltd. Basic Information List
Table 110. Jiangsu Nhwa Pharmaceutical Co., Ltd. Description and Business Overview
Table 111. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in Central Nervous System (CNS) Drug Business of Jiangsu Nhwa Pharmaceutical Co., Ltd. (2024-2024)
Table 113. Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments
Table 114. North America Central Nervous System (CNS) Drug Market Size by Country (2024-2024) & (US$ Million)
Table 115. North America Central Nervous System (CNS) Drug Market Size by Country (2024-2034) & (US$ Million)
Table 116. Europe Central Nervous System (CNS) Drug Market Size by Country (2024-2024) & (US$ Million)
Table 117. Europe Central Nervous System (CNS) Drug Market Size by Country (2024-2034) & (US$ Million)
Table 118. Asia-Pacific Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 119. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2024-2024) & (US$ Million)
Table 120. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2024-2034) & (US$ Million)
Table 121. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Region (2024-2024)
Table 122. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Region (2024-2034)
Table 123. Latin America Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 124. Latin America Central Nervous System (CNS) Drug Market Size by Country (2024-2024) & (US$ Million)
Table 125. Latin America Central Nervous System (CNS) Drug Market Size by Country (2024-2034) & (US$ Million)
Table 126. Middle East & Africa Central Nervous System (CNS) Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 127. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2024-2024) & (US$ Million)
Table 128. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2024-2034) & (US$ Million)
Table 129. Central Nervous System (CNS) Drug Market Trends
Table 130. Central Nervous System (CNS) Drug Market Drivers
Table 131. Central Nervous System (CNS) Drug Market Challenges
Table 132. Central Nervous System (CNS) Drug Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Central Nervous System (CNS) Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Central Nervous System (CNS) Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Central Nervous System (CNS) Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Central Nervous System (CNS) Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Central Nervous System (CNS) Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Central Nervous System (CNS) Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Central Nervous System (CNS) Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Central Nervous System (CNS) Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Central Nervous System (CNS) Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Prescription Drugs
Figure 11. Global Prescription Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of OTC
Figure 13. Global OTC Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Central Nervous System (CNS) Drug Market Size Share by Type: 2022 & 2034
Figure 15. North America Central Nervous System (CNS) Drug Revenue Market Share by Type (2024-2034)
Figure 16. Europe Central Nervous System (CNS) Drug Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Central Nervous System (CNS) Drug Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Central Nervous System (CNS) Drug Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Central Nervous System (CNS) Drug Revenue Market Share by Type (2024-2034)
Figure 20. MS Therapeutics Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Antipsychotic Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Depression Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Epilepsy Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Central Nervous System (CNS) Drug Market Size Share by Application: 2022 & 2034
Figure 26. North America Central Nervous System (CNS) Drug Revenue Market Share by Application (2024-2034)
Figure 27. Europe Central Nervous System (CNS) Drug Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Central Nervous System (CNS) Drug Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Central Nervous System (CNS) Drug Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Central Nervous System (CNS) Drug Revenue Market Share by Application (2024-2034)
Figure 31. Central Nervous System (CNS) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Central Nervous System (CNS) Drug Market Share in 2022
Figure 33. North America Central Nervous System (CNS) Drug Market Share by Country (2024-2034)
Figure 34. U.S. Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 37. France Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Region (2024-2034)
Figure 43. China Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 47. India Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Central Nervous System (CNS) Drug Market Share by Country (2024-2034)
Figure 50. Mexico Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Central Nervous System (CNS) Drug Market Share by Country (2024-2034)
Figure 53. Turkey Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Central Nervous System (CNS) Drug Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries